Company Description
Novanta Inc., together with its subsidiaries, provides precision medicine, precision manufacturing, medical solutions, robotics and automation solutions, and advanced surgery solutions in the United States and internationally.
It operates in two segments, Automation Enabling Technologies and Medical Solutions. The Precision Medicine and Manufacturing segment designs, manufactures, and markets laser beam delivery components, laser beam delivery solutions, CO2 lasers, solid state lasers, ultrafast lasers, optical and inductive encoders, precision motors, integrated stepper motors, servo drives, motion control solutions, intelligent robotic end-of-arm technology solutions, and air bearing spindles.
This segment serves advanced industrial processes, advanced industrial and medical robotics, other medical and life science automation applications, and medical laser procedures, such as ophthalmology applications.
The Medical Solutions segment provides a range of medical grade technologies, including medical insufflators, pumps, and related disposables; laser beam delivery solutions; video processing, streaming, and capture; machine vision technologies; radio frequency identification (RFID) technologies; barcode identification technologies; thermal chart recorders; light and color measurement technologies; touch panel displays; and advanced motion control solutions.
The company sells its products through its direct sales force and distributors under the Cambridge Technology, Synrad, Laser Quantum, ARGES, WOM, NDS, Med X Change, Reach Technology, JADAK, ThingMagic, Photo Research, General Scanning, ATI Industrial Automation, Celera Motion, IMS, MicroE, Applimotion, Zettlex, Ingenia, and Westwind brands.
The company was formerly known as GSI Group, Inc. and changed its name to Novanta Inc. in May 2016.
Novanta Inc. was incorporated in 1968 and is headquartered in Bedford, Massachusetts.
| Country | United States |
| Founded | 1968 |
| Industry | Scientific & Technical Instruments |
| Sector | Technology |
| Employees | 3,000 |
| CEO | Matthijs Glastra |
Contact Details
Address: 125 Middlesex Turnpike Bedford, Massachusetts 01730 United States | |
| Phone | 781 266 5700 |
| Website | novanta.com |
Stock Details
| Ticker Symbol | NOVT |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001076930 |
| CUSIP Number | 67000B104 |
| ISIN Number | CA67000B1040 |
| Employer ID | 98-0110412 |
| SIC Code | 3690 |
Key Executives
| Name | Position |
|---|---|
| Matthijs Glastra | Chief Executive Officer and Chairman of the Board |
| Robert J. Buckley | Chief Financial Officer |
| Michele Davis Michele Welsh | General Counsel and Corporate Secretary |
| John Joseph Burke II | Chief Accounting Officer and Corporate Controller |
| Ray Nash | Corporate Finance Leader and IR |
| Sarah Betadam | Chief Information Officer and Chief Information Security Officer |
| Nissia Sabri | Senior Vice President of Corporate Development |
| Chuck Ravetto | Co-Chief Operating Officer of Automation Enabling Technologies |
| Anna Fain | Senior Vice President of Leadership Development and Diversity, Equity and Inclusion |
| John Lesica | Co-Chief Operating Officer of Medical Solutions |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Feb 25, 2025 | 8-K | Current Report |
| Feb 25, 2025 | S-3ASR | Automatic shelf registration statement of securities of well-known seasoned issuers |
| Feb 25, 2025 | 10-K | Annual Report |
| Feb 25, 2025 | 8-K | Current Report |
| Dec 2, 2024 | 144 | Filing |
| Nov 14, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
| Nov 12, 2024 | 144 | Filing |
| Nov 8, 2024 | 144 | Filing |
| Nov 5, 2024 | 10-Q | Quarterly Report |
| Nov 5, 2024 | 8-K | Current Report |